These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1837118)

  • 1. [Functional reversibility of chronic cyclosporine nephrotoxicity in patients after kidney transplantation].
    Mourad G; Halimi JM; Ribstein J; Mimran A; Mion C
    Presse Med; 1991 Nov; 20(40):2028-9. PubMed ID: 1837118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.
    Mourad G; Vela C; Ribstein J; Mimran A
    Transplantation; 1998 Mar; 65(5):661-7. PubMed ID: 9521200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
    Pei Y; Scholey JW; Katz A; Schachter R; Murphy GF; Cattran D
    Am J Kidney Dis; 1994 Apr; 23(4):528-36. PubMed ID: 8154488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic cyclosporine nephrotoxicity.
    Andoh TF; Bennett WM
    Curr Opin Nephrol Hypertens; 1998 May; 7(3):265-70. PubMed ID: 9617556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-associated chronic nephropathy.
    Myers BD; Ross J; Newton L; Luetscher J; Perlroth M
    N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple-drug immunosuppression for over 2 years.
    Klompmaker IJ; Homan van der Heide JJ; Tegzess AM; Meijer S; Haagsma EB; Verwer R; Slooff MJ
    Nephrol Dial Transplant; 1994; 9(11):1629-33. PubMed ID: 7870353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of cyclosporine on renal function in organ transplant recipients.
    Bantle JP; Paller MS; Boudreau RJ; Olivari MT; Ferris TF
    J Lab Clin Med; 1990 Feb; 115(2):233-40. PubMed ID: 2405085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cyclosporin-induced nephropathy.
    Takahara S; Ota K; Takahashi K; Uchida K; Morozumi K; Wang JD; Kyo M;
    Clin Nephrol; 2001 Jan; 55(1):69-72. PubMed ID: 11200870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients.
    Chan C; Maurer J; Cardella C; Cattran D; Pei Y
    Transplantation; 1997 May; 63(10):1435-40. PubMed ID: 9175807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
    Koller-Strametz J; Wolzt M; Fuchs C; Putz D; Wisser W; Mensik C; Eichler HG; Laufer G; Schmetterer L
    Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of cyclosporine to sirolimus before 12 months is associated with marked improvement in renal function and low proteinuria in a South African renal transplant population.
    Maharaj S; Assounga AG
    Exp Clin Transplant; 2010 Mar; 8(1):14-8. PubMed ID: 20199366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of lithium clearance studies in the early detection of cyclosporin A (CsA) nephrotoxicity: a protocol of renal function assessment with CsA therapy.
    Dick AD; Towler HM; Whiting P; Forrester JV
    Curr Eye Res; 1992; 11 Suppl():215-8. PubMed ID: 1424748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal fibrosis in cyclosporin A-treated renal allograft recipients: morphological findings in relation to renal hemodynamics.
    Jacobson SH; Jaremko G; Duraj FF; Wilczek HE
    Transpl Int; 1996; 9(5):492-8. PubMed ID: 8875793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplanted recipients.
    Xu F; Huang JB; Jiang L; Xu J; Mi J
    Nephrol Dial Transplant; 1995; 10(1):142-3. PubMed ID: 7724020
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
    Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine nephropathy: pathophysiology and clinical impact.
    Shihab FS
    Semin Nephrol; 1996 Nov; 16(6):536-47. PubMed ID: 9125798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.